Reference is hereby made to that certain License Agreement between FB Health S.p.A (“FB Health”) and [[Organization A:Organization]] (“Bellus”), of even date herewith (the “Bellus License Agreement”). All capitalized terms used but not defined herein shall have the meaning set forth in the Bellus License Agreement.

As you are aware, pursuant to the Bellus License Agreement, Bellus has licensed to FB Health certain Patent Rights and Know-How owned or Controlled by Bellus and has granted to FB Health certain rights related thereto. As contemplated by [Section 2.3] of the Bellus License Agreement, simultaneously with the execution of this letter agreement (this “Letter Agreement”), FB Health is entering into an agreement with [[Organization B:Organization]] pursuant to which FB Health is sublicensing to [[Organization B:Organization]] all of the rights licensed or otherwise granted to FB Health by [[Organization B:Organization]] under the Bellus License Agreement, subject to certain rights retained by FB Health with respect to Italy (the “[[Organization B:Organization]] Sublicense Agreement”). The [[Organization B:Organization]] Sublicense Agreement is attached hereto as [Exhibit A]. By executing this Letter Agreement, Bellus hereby acknowledges that FB Health is granting a sublicense of its rights under the Bellus Agreement to [[Organization B:Organization]] in accordance with [Section 2.3] of the Bellus License Agreement and consents to such sublicense and other assignment of rights granted in the [[Organization B:Organization]] Sublicense Agreement.